Nevertheless, 33% of Faslpr/lpr mice still develop B cell lymphomas in an OPN-competent setting, suggesting that, in mice characterized by a high inflammation associated with autoimmune condition, the endogenous iOPN is not sufficient to completely halt B cell transformation. The gene discussed is SPP1; the disease is B-cell non-Hodgkin lymphoma.